This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. (INO) slid 6.15% to $1.22 Monday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.32% to 49,686.12 and the NASDAQ Composite Index falling 0.51% to 26,090.73.
This was the stock's second consecutive day of losses.
Inovio Pharmaceuticals Inc. closed 59.05% below its 52-week high of $2.98, which the company achieved on September 9th.
The stock underperformed when compared to some of its competitors Monday, as Johnson &amp; Johnson (JNJ) rose 0.97% to $228.92, Statera Biopharma Inc. (STAB) remained unchanged, and Pfizer Inc. (PFE) remained unchanged.
Trading volume (5.3 M) eclipsed its 50-day average volume of 2.7 M.
Data source: Dow Jones Market Data, FactSet. Data compiled May 18, 2026.
This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
05-18-26 1724ET

IBBQ

LABD

LABU

Inovio Pharmaceuticals Inc. (INO) shares fell 6.15% to $1.22 on Monday, marking the second consecutive day of losses. The stock is now 59.05% below its 52-week high of $2.98. In contrast, competitors like Johnson & Johnson and Pfizer remained stable, while the overall market showed mixed results with the Dow up 0.32% and NASDAQ down 0.51%. Trading volume was 5.3 million, surpassing the 50-day average of 2.7 million.

MarketWatch Automated

Inovio Pharma

VanEck Biotech ETF

Proshares Ultra Nasdaq Biotech

Invesco Biotechnology & Genome ETF

Invesco Nasdaq Biotechnology ETF

iShares Biotechnology ETF

SPDR S&P Biotech

Direxion S&P Biotech Bear 3X

First Trust NYSE Arca Biotech Index Fd

Direxion S&P Biotech Bull 3X

Dow Jones Industrial Average

NASDAQ Composite Index

Johnson & Johnson

Pfizer

Inovio Pharmaceuticals Inc. Stock Underperforms Monday When Compared To Competitors